MEAGHAN REYNOLDS: Open Payments
NPI 1477782324 · NORTH EASTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,005 in 269 payments from 37 companies in 2025. Trend: 2023 $4,927 · 2024 $6,424 · 2025 $6,005
Food & beverage: $5,848Education: $157
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $881 |
| Novartis Pharmaceuticals Corporation | 18 | $620 |
| Biogen, Inc. | 23 | $483 |
| Lundbeck LLC | 21 | $391 |
| Amneal Pharmaceuticals LLC | 12 | $289 |
| Merz Pharmaceuticals, LLC | 10 | $270 |
| UCB, Inc. | 16 | $254 |
| Lilly USA, LLC | 11 | $249 |
| SK Life Science, Inc. | 8 | $225 |
| Teva Pharmaceuticals USA, Inc. | 5 | $218 |
Products named: KESIMPTA, QULIPTA, LEQEMBI, UBRELVY, VYEPTI, Xeomin, TYSABRI, KISUNLA.
Industry payments across MA — which companies pay providers there.
